On 13 and 14 March, the annual meeting of HHT Europe will be held in Rome, where important topics related to HHT will be updated, examples of good practices and successes of national organisations will be presented, and new projects will be promoted.
The main topics to be discussed are as follows:

• Drug Development – Understanding the process and Role of Patient Organisations
• What is in development – Horizon Scanning of Clinical Trials for HHT
• Vaderis presents: VAD044, Results of proof of concept study and introduction to the Phase III trial
• Mapping of HHT Centres – overview and proposals
• Iron Management in HHT
• Antiplatlet therapy in HHT patients – evidence from the multicentric PRIN study
• How to use the consensus paper on sclerotherapy in your national setting
• New consensus for assessing the severity of epistaxis

One of the most important parts of the conference is sharing the best and most successful practices of organisations and creating working groups to launch new and interesting projects.